Phreesia Inc

Phreesia Inc

PHR

Get informed when a big investor buys or sells

+ Follow
Market Cap$668.19M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Phreesia IncPhreesia Inc62.8--2%1.40.3
$11.33

Target Price by Analysts

2.7% upsidePhreesia Target Price DetailsTarget Price
$29.73

Current Fair Value

169.3% upside

Undervalued by 169.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$668.19 Million
Enterprise Value$696.44 Million
Dividend Yield$- (-)
Earnings per Share$0.04
Beta0.84
Outstanding Shares61,878,316

Return

Return on Equity-1.58%ROE
Return on Assets-0.91%
Return on Invested Capital1.67%

Valuation & Multiples

P/E Ratio62.78P/E Ratio
PEG10.51PEG
Price to Sales1.38Price to Sales
Price to Book Ratio1.84Price to Book Ratio
Enterprise Value to Revenue1.37
Enterprise Value to EBIT82.79
Enterprise Value to Net Income-119
Total Debt to Enterprise0.15
Debt to Equity0.27Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
September 3, 2026
EPS Estimate
$0.11
Average shareholder expectation
Revenue Estimate
$129.06 M
Average shareholder expectation

Next Earnings Call

Expected Date
December 14, 2026
EPS Estimate
$0.13
Average shareholder expectation
Revenue Estimate
$128.43 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000▼ 29.16%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.01%▼ 95.05%
Total Invested$66,030▼ 99.99%
Investors Holding4▼ 233.00%

ESG Score

No data

About Phreesia Inc

CEO: Chaim Indig

Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients and provides a modern, convenient experience, while enabling our clients to optimi...